Basic research can lead to the development of new diagnostic approaches or treatments that need to be evaluated for effectiveness and safety through clinical studies.
The progress of a clinical trial
Voluntary participation in clinical trials plays a crucial role in advancing medical research. By engaging in these studies, volunteers undergo a specific care pathway, defined according to the protocol's requirements (refer to the diagram below for more details). They benefit from regular monitoring provided by a team of professionals, including nurses, clinical research associates, and physicians.
-
If you wish to participate in a clinical trial, do not hesitate to discuss it with your neurologist.
-
To precisely understand the progress of a clinical trial and the conditions for participation, download the brochure 'Participating in a Clinical Trial'.
-You can also consult the list of ongoing research projects at the following links:
-According to the information provided on the ClinicalTrials.gov website (as of June 2022):
Internationally, 2695 studies have been conducted or are ongoing (including ongoing and completed studies) in the field of MS and associated diseases. At the national level, 152 studies are currently ongoing in France (with results not yet published in scientific journals).
Among these 152 studies:
- 34% focus on therapeutic clinical trials in MS
- 30% focus on clinical trials on biomarkers (imaging and/or biological) in MS
- 22% focus on clinical trials aiming at evaluating and monitoring symptoms in MS
- 6% focus on retrospective data collection (epidemiological data registries including the national databases EDMUS and NOMADMUS managed by OFSEP)
- 8% focus on clinical trials related to rare inflammatory diseases of the central nervous system (MOGAD - NMOSD)
Currently, two-thirds of clinical trials in multiple sclerosis or associated rare inflammatory diseases stem from academic research, conducted by institutions, healthcare facilities, or public hospitals.
